STARTUPS

1st Batch

United Immunity Co., Ltd.

United Immunity aims to cure cancer by overcoming "Cold tumor" through the practical application of T cell activation technology "T-ignite", which was born from medical-engineering collaboration research between Mie University and Kyoto University. Cold tumor is an immunologically inactive cancer that immune checkpoint inhibitors are difficult to work on, which account for the majority of malignant tumors. Thus, there is a global need for understanding the causes and solutions of Cold tumor.

http://unitedimmunity.co.jp/

1st Batch

Mealthy

Mealthy provides SaaS for dietary habits improvement support to prevent lifestyle-related diseases. Currently, Mealthy's service is used in health insurance associations and supporting insured people to continue their healthcare program of specific health guidance and prevention of diabetic nephropathy. Mealthy is promoting the automation of nutritionist operations while maintaining high-quality nutrition guidance at the medical level. Mealthy's service has already used at health insurance associations and achieved the industry's top level cost-effectiveness.

https://mealthy.me/

1st Batch

Domolens

Domolens is developing and researching the world's first VR product to improve stuttering, an unknown language disorder with 1.2 million people in Japan and 76 million people in the world. People with stuttering improve their symptoms by experiencing social scenes that they are not good at in VR space over and over again.

https://infoadversity.wixsite.com/adversity/

1st Batch

ERISA

ERISA was established in Matsue City, Shimane Prefecture in April 2017 as a subsidiary of a regional think tank with over 20 years of business experience. ERISA aims to commercialize a program which can predict progression to Alzheimer-type dementia from mild cognitive impairment based on MR images using AI, with the goal of solving the social problem of dementia in Shimane, an aging advanced prefecture in Japan.

https://www.erisa.co.jp/